IHI Corporation
IHICY | OTC
$14.75
+$0.26 (+1.79%)
Nov 2, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Revenue | 1.64T | 1.63T | 1.32T | 1.35T | 1.17T | 1.11T |
Cost of Revenue | 1.26T | 1.25T | 1.18T | 1.07T | 963.5B | 932.93B |
Gross Profit | 379.51B | 374.51B | 144.86B | 282.01B | 209.41B | 179.97B |
Operating Income | 136.82B | 143.52B | -70.14B | 81.99B | 81.5B | 27.96B |
Interest Income | 14.78B | 3.73B | 4.9B | 872M | 9.58B | 6.7B |
Pretax Income | 185.49B | 138.49B | -72.28B | 64.87B | 87.64B | 27.62B |
Net Income | 160.99B | 112.74B | -68.21B | 44.55B | 66.07B | 13.09B |
Selling & General & Admin | 242.7B | 223.64B | 212.84B | 201.16B | 176.6B | 164.23B |
Research & Development | n/a | 33.23B | 38.88B | 32.11B | 28.68B | 24.95B |
Other Expenses | n/a | -25.87B | -36.72B | -33.25B | -77.37B | -37.16B |
Operating Expenses | 242.7B | 231B | 214.99B | 200.02B | 127.91B | 152.01B |
Interest Expense | 9.06B | 15.03B | 7.82B | 4.94B | 4.62B | 5.11B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.51T | 1.48T | 1.39T | 1.27T | 1.09T | 1.08T |
Income Tax Expense | 20.27B | 21.19B | -7.43B | 16.49B | 18.72B | 10.66B |
Shares Outstanding (Basic) | 1.06B | 1.06B | 1.06B | 1.06B | 1.05B | 1.04B |
Shares Outstanding (Diluted) | 1.06B | 1.06B | 1.06B | 1.06B | 1.05B | 1.04B |
EPS (Basic) | 151.88 | 106.41 | -64.40 | 42.07 | 62.82 | 12.59 |
EPS (Diluted) | 151.86 | 106.40 | -64.40 | 42.06 | 62.82 | 12.59 |
EBITDA | 281.37B | 190.62B | -28.66B | 122.32B | 99.64B | 81.83B |
EBIT | 194.55B | 146.64B | -71.51B | 80.03B | 25.2B | 5.39B |
Depreciation & Amortization | 86.82B | 43.98B | 42.85B | 42.29B | 74.44B | 76.44B |
Add to Watchlist
Select watchlists to add or remove IHICY